Marvin Miller, Ph.D. has been selected for induction into the American Chemical Society (ACS) Division of Medicinal Chemistry (MEDI) Hall of Fame during the ACS 252nd National Meeting and Exposition in Philadelphia in late August.
For nearly 40 years, Professor Miller has made countless contributions to medicinal chemistry, focusing on a mixture of synthetic organic chemistry and bioorganic chemistry to develop new methods in an effort to study, prevent, and cure disease, in particular tuberculosis and malaria.
Professor Miller has over 300 peer reviewed publications and more than 25 US patents. A popular lecturer across the country and around the world, he has mentored more than 80 graduate students and 70 postdoctoral researchers and visiting scientists. On nominating Miller, Shahriar Mobashery, Ph.D., the Navari Family Professor of Life Sciences at Notre Dame, wrote, “His service to the profession, his membership on a number of editorial advisory boards and grant review panels and popularity as a consultant worldwide, and his reputation for superb training and placement of lab workers has been remarkable. His chemistry is noted for being innovative, yet practical and reproducible.”
Mobashery’s sentiments were echoed by John Macor, Ph.D., Executive Director Immunoscience Discovery Chemistry, Bristol Myers Squibb, who wrote about Miller, “His commitment to both research in organic and medicinal chemistry, coupled with his devotion to training the next generation of organic and medicinal chemists makes him the ideal candidate for the MEDI Hall of Fame.”
Professor Miller joined the College of Science in 1977 after receiving a Ph.D. In Bioorganic Chemistry from Cornell University and following postdoctoral work at the University of California-Berkeley. In 1996, Miller was named the George & Winifred Clark Professor of Chemistry and Biochemistry at the University of Notre Dame.
Originally published by Tammi Freehling at science.nd.edu on August 05, 2016.